Ontology highlight
ABSTRACT: Background
Morning hypertension is a risk factor for cardiovascular and cerebrovascular events, and consequently diagnosis and control of morning hypertension are considered very important. We previously reported the results of the Azelnidipine Treatment for Hypertension Open-label Monitoring in the Early morning (At-HOME) Study, which indicated that azelnidipine effectively controlled morning hypertension.Objectives
The objective of this At-HOME subgroup analysis was to evaluate the sustained blood pressure (BP)-lowering effect of azelnidipine, using mean morning and evening systolic BP [ME average] and morning systolic BP minus evening systolic BP (ME difference).Methods
We analyzed the self-measured home BP data (measured in the morning and at bedtime) from this
SUBMITTER: Kario K
PROVIDER: S-EPMC3627021 | biostudies-literature | 2013 Mar
REPOSITORIES: biostudies-literature